Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Biofinderon Jun 05, 2018 2:19pm

164 Views

Post# 28127442

RE:RE:Plasminogen: estimated $8 Billion USD untapped WW market

Fear monger trapped in a box of your own making who can’t look past the obvious. Continue to play conservative and timid, continue to listen to the experts who have your beat interests in mind, continue to read the charts for the charts are never wrong. It’s your money you do what you want, I already have mine. And now we wait.

HighteawithIntrepid wrote: Until we get our lack of cash issues worked out I’m not looking past
September. And I would suggest that you look at gross margins not
sales as we will have selling commissions and cost of goods sold and
the financial reality is we will not magically not have our current costs and
I am pretty sure PL and other staff will want a raise. Try not to look past
the next box to be ticked and I see that as a release of Q2 and Q3 and then
pray for a FDA yes in mid Q4.